{"id":"https://openalex.org/W3216719922","doi":"https://doi.org/10.1182/blood-2021-149297","title":"Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell Transplant","display_name":"Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell Transplant","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3216719922","doi":"https://doi.org/10.1182/blood-2021-149297","mag":"3216719922"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-149297","doi":"https://doi.org/10.1182/blood-2021-149297","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-149297","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035797566","display_name":"Mateo Mej\u00eda Saldarriaga","orcid":"https://orcid.org/0000-0002-3504-5597","observed_orcids":["https://orcid.org/0000-0002-3504-5597"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mateo Mejia Saldarriaga","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087414237","display_name":"Yassine Tahri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Yassine Tahri","raw_affiliation_strings":["Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 Libre de Bruxelles, Brussels, Belgium","institution_ids":["https://openalex.org/I132053463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100319638","display_name":"Sangmin Lee","orcid":"https://orcid.org/0000-0003-3136-9292","observed_orcids":["https://orcid.org/0000-0003-3136-9292"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sangmin Lee","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100619742","display_name":"Zhengming Chen","orcid":"https://orcid.org/0000-0001-9437-6452","observed_orcids":["https://orcid.org/0000-0001-9437-6452"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengming Chen","raw_affiliation_strings":["Population Health Sciences, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Population Health Sciences, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071121646","display_name":"Tsiporah B. Shore","orcid":"https://orcid.org/0000-0001-6033-0747","observed_orcids":["https://orcid.org/0000-0001-6033-0747"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tsiporah B. Shore","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004529847","display_name":"Danielle Guarneri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Guarneri","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101506577","display_name":"Sebastian Alexander Mayer","orcid":"https://orcid.org/0000-0003-1648-1382","observed_orcids":["https://orcid.org/0000-0003-1648-1382"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sebastian A. Mayer","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049384875","display_name":"Adrienne Alise Phillips","orcid":"https://orcid.org/0000-0003-2024-3483","observed_orcids":["https://orcid.org/0000-0003-2024-3483"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrienne A. Phillips","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061064204","display_name":"Alexandra Gomez-Arteaga","orcid":"https://orcid.org/0000-0003-0897-3790","observed_orcids":["https://orcid.org/0000-0003-0897-3790"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Gomez-Arteaga","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076552127","display_name":"Pinkal M. Desai","orcid":"https://orcid.org/0000-0002-9816-7284","observed_orcids":["https://orcid.org/0000-0002-9816-7284"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pinkal Desai","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078887304","display_name":"Ellen Kelly Ritchie","orcid":"https://orcid.org/0000-0001-8150-5542","observed_orcids":["https://orcid.org/0000-0001-8150-5542"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen Ritchie","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medical College New York Presbyterian, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medical College New York Presbyterian, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael B. Samuel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Samuel","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012863731","display_name":"Gail J. Roboz","orcid":"https://orcid.org/0000-0002-0384-3658","observed_orcids":["https://orcid.org/0000-0002-0384-3658"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail J. Roboz","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044134864","display_name":"Koen van Besien","orcid":"https://orcid.org/0000-0002-8164-6211","observed_orcids":["https://orcid.org/0000-0002-8164-6211"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koen van Besien","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086433558","display_name":"Jingmei Hsu","orcid":"https://orcid.org/0009-0002-4055-0616","observed_orcids":["https://orcid.org/0009-0002-4055-0616"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingmei Hsu","raw_affiliation_strings":["Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"4833","last_page":"4833"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9589999914169312},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mutation","display_name":"genetic mutations","score":0.7710000276565552},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.734000027179718},{"id":"https://openalex.org/keywords/dnmt3a-mutation","display_name":"DNMT3A mutation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/asxl1-mutation","display_name":"ASXL1 mutation","score":0.8809999823570251},{"id":"https://openalex.org/keywords/tet2-mutation","display_name":"TET2 mutation","score":0.968999981880188},{"id":"https://openalex.org/keywords/idh-mutation","display_name":"IDH mutation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.597000002861023},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.9789999723434448},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.7126232981681824},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6111063957214355},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6097038984298706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.596623420715332},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5452703237533569},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5282670259475708},{"id":"https://openalex.org/C2483381","wikidata":"https://www.wikidata.org/wiki/Q18030194","display_name":"NPM1","level":5,"score":0.4421634078025818},{"id":"https://openalex.org/C2994225774","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Gene mutation","level":4,"score":0.4214155673980713},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.25017306208610535},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17212089896202087},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16669568419456482},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12070739269256592},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10918617248535156},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.10782432556152344},{"id":"https://openalex.org/C53226629","wikidata":"https://www.wikidata.org/wiki/Q189967","display_name":"Karyotype","level":4,"score":0.0},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-149297","doi":"https://doi.org/10.1182/blood-2021-149297","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-149297","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980998096","https://openalex.org/W4391603223","https://openalex.org/W2912870107","https://openalex.org/W2549900445","https://openalex.org/W2986854965","https://openalex.org/W2167029308","https://openalex.org/W2953217976","https://openalex.org/W7160551803","https://openalex.org/W2563889965","https://openalex.org/W2157032869"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Acute":[2],"myeloid":[3],"leukemia":[4],"(AML)":[5],"is":[6,182],"heterogenous":[7],"disease":[8,122],"with":[9,94,184,200,322,341,371,396,461,490,499,508,549,603,633,657],"a":[10,295,500,509],"range":[11],"of":[12,43,61,127,179,196,221,239,286,299,314,381,598,607,618,641,644,651,697,709,721,733],"cytogenetic":[13],"and":[14,29,36,63,107,133,166,188,252,260,266,288,333,362,364,412,477,514,533,568,587,623,636],"molecular":[15,18,96,136,167,201,383],"changes.":[16],"Several":[17],"mutations":[19,44,144,241,257,290,315,399,600,619,660,676],"identified":[20],"in":[21,33,69,87,226,284,316,422,450,620,654,664,680,783],"AML":[22,70,83,198,655],"patients":[23,71,84,199,223,395,656],"at":[24,98,210,244,318,367],"diagnosis":[25,245,319,368],"have":[26],"prognostic":[27,41],"implications":[28],"play":[30],"important":[31],"roles":[32],"guiding":[34],"induction":[35],"consolidative":[37],"treatment":[38],"decisions.":[39],"The":[40,229,312],"impact":[42,390,612],"peri":[45],"allogeneic":[46,77,105,629],"stem":[47,78],"cell":[48,79],"transplant":[49,80,387,667],"are":[50,86,224],"less":[51,272],"well":[52],"characterized.":[53],"In":[54],"this":[55],"study,":[56],"we":[57],"examine":[58],"the":[59,176,222,255,302,307,423,639,784],"significance":[60],"pre":[62],"by":[64,108,142,253,325,400,661],"D100":[65,401,662],"Post-transplant":[66,669],"mutation":[67,97,384,609],"status":[68],"underwent":[72],"Fludarabine/Melphalan":[73],"conditioned":[74],"reduced":[75,344,360,421,665],"intensity":[76,666],"(SCT).":[81],"Methods:":[82],"who":[85],"morphologic":[88],"complete":[89],"remission":[90],"(CR1":[91],"or":[92,280,392,453,614,699,711,723,735],"greater)":[93],"available":[95,204],"diagnosis,":[99],"within":[100],"6":[101],"weeks":[102],"prior":[103,291,385],"to":[104,174,207,249,292,347,386],"SCT,":[106],"100":[109],"days":[110],"post-transplant":[111,663],"were":[112,217,242,258,420,631],"included.":[113],"Variables":[114],"analyzed":[115],"included":[116],"baseline":[117],"demographics,":[118],"clinical":[119,551],"variables":[120],"(CIBMTR":[121],"risk":[123],"index":[124],"(DRI),":[125],"type":[126],"transplant,":[128],"ELN":[129],"risk,":[130],"performance":[131],"status)":[132],"23":[134],"recurring":[135],"mutations.":[137],"Analysis":[138,437],"was":[139,160,172,232,271,309,320,369,458,487,601],"also":[140],"performed":[141],"grouping":[143],"into":[145],"six":[146,440],"pre-defined":[147],"gene":[148,152],"groups":[149,442],"based":[150,438],"on":[151,274,428,439,693,705,717,729],"function":[153],"(Table":[154,246],"2).":[155],"Multivariable":[156],"cox":[157],"regression":[158],"analysis":[159,335,430,557,648],"adjusted":[161],"for":[162,306,505,516,558],"age,":[163],"gender,":[164],"DRI":[165,353],"mutation.":[168],"Backward":[169],"selection":[170],"method":[171],"used":[173],"select":[175],"best":[177],"combination":[178],"genes":[180],"that":[181,671],"associated":[183,321,370,460,489,602,632],"overall":[185,304],"survival":[186,190,305],"(OS)":[187],"relapse-free":[189],"(RFS).":[191],"Results":[192],":":[193],"A":[194],"total":[195],"142":[197],"genetic":[202],"data":[203],"from":[205,345],"2014":[206],"June,":[208],"2020":[209],"Weill":[211],"Cornell":[212],"Medicine/New":[213],"York":[214],"Presbyterian":[215],"Hospital":[216],"analyzed.":[218],"Clinical":[219],"characteristics":[220],"summarized":[225],"Table":[227],"1.":[228,686],"median":[230,296,303,342],"age":[231],"58":[233],"years":[234],"(range":[235],"20":[236],"-78).":[237],"Total":[238],"261":[240],"detectable":[243,256],"3).":[247],"Prior":[248],"allo":[250],"SCT":[251,630],"D100,":[254],"87":[259],"40":[261],"respectively,":[262],"which":[263],"represent":[264],"56":[265],"26":[267],"patients.":[268],"High-dose":[269],"chemotherapy":[270],"effective":[273],"clearing":[275],"DNMT3A,":[276],"ASXL1,":[277],"TET2":[278,470,492,559],"(DAT)":[279],"IDH":[281,289],"mutations,":[282],"resulting":[283],"over-representation":[285],"DAT":[287],"transplant.":[293],"With":[294],"follow-up":[297],"time":[298],"25":[300],"months,":[301,787],"group":[308],"40.8":[310],"months.":[311],"presence":[313,617],"TP53":[317,599],"worse":[323,372,456,503,550,604],"OS":[324,343,361,373,391,404,452,486,504,513,561,637],"both":[326,403],"univariate":[327,424],"(HR":[328,336,354,374,414,431,464,471,479,493],"3.67,":[329],"p=0.0030,":[330],"CI":[331,339,357,376,410,418,435,468,475,483,497,523,531,540,546,574,583,593],"1.56-8.68)":[332],"multivariate":[334,429,556],"4.75,":[337],"p=0.0014,":[338],"1.82-12.39)":[340],"49.3":[346],"19.3":[348],"months":[349],"(p=0.002).":[350],"High":[351],"CIBMTR":[352,645],"0.17,":[355],"p=0.0018,":[356],"0.05-0.51)":[358],"predicted":[359],"RFS,":[363],"Age":[365],">60":[366],"1.7":[375],"1.04-3,":[377],"p":[378,408,416,433,466,481,495,521,529,538,544,564,572,581],"0.03).":[379],"Presence":[380,597,606],"any":[382,397,448],"did":[388,445,610],"not":[389,427,446,611],"RFS.":[393,454],"For":[394],"persistent":[398,462,491,659,675],"post-transplant,":[402],"(":[405],"HR":[406,519,527,536,562,570,579,590],"2.04,":[407],"0.027,":[409],"1.08-3.8)":[411],"RFS":[413,457,515,526,542,569,613,635],"1.99,":[415],"0.025,":[417],"1.09-3.6,)":[419],"analysis,":[425],"but":[426],"1.88,":[432],"0.5,":[434],"0.99-3.49).":[436],"mutational":[441],"(table":[443],"2)":[444],"show":[447],"difference":[449],"their":[451],"However,":[455],"independently":[459,488],"IDH1":[463,577,622],"3.8,":[465],"0.004,":[467],"1.07-56,),":[469],"3.9,":[472,494],"P":[473],"0.04,":[474],"1.04-14.1),":[476,498],"FLT3-ITD":[478,588,624],"4.5,":[480],"0.01,":[482],"1.7-52).":[484],"Worse":[485],"0.013,":[496],"trend":[501,510],"towards":[502,511],"IDH1,":[506],"FLT3-ITD,":[507],"worsening":[512],"ASXL1":[517],"(OS":[518,535],"7.4,":[520],"0.06,":[522,530],"0.86":[524],"-63;":[525],"4.9,":[528],"0.9-26)":[532],"DNMT3A":[534],"2.3,":[537],"0.12,":[539],"0.86-6.9;":[541],"2.9,":[543],"0.08,":[545],"0.98-8).":[547],"Association":[548],"outcomes":[552,653],"remained":[553],"significant":[554],"after":[555,625],"(both":[560],"3.98":[563],"0.041,":[565],"CI1.07-":[566],"32":[567],"5.8,":[571],"0.032,":[573],"1.1-":[575],"29),":[576],"(RFS":[578,589],"8.02,":[580],"0.049,":[582],"1.02":[584],"-":[585,825],"65)":[586],"11.4,":[591],"p0.010,":[592],"2.2-":[594],"80).":[595],"Conclusions:":[596],"OS.":[605,615],"pre-transplant":[608],"Persistent":[616],"TET2,":[621],"Fludarabine/melphalan":[626],"conditioning":[627],"regimen":[628],"shorter":[634],"(in":[638],"case":[640],"TET2)":[642],"independent":[643],"DRI.":[646],"This":[647],"supports":[649],"association":[650],"adverse":[652],"selected":[658],"setting.":[668],"strategies":[670],"can":[672],"further":[673],"eliminate":[674],"should":[677],"be":[678],"investigated":[679],"prospective":[681],"studies.":[682],"Figure":[683,685],"1":[684],"Disclosures":[687],"Lee:":[688],"Pin":[689],"Therapeutics:":[690,857],"Consultancy,":[691,703,715,727,759,762,767,776,791,801,804,812,815,819],"Membership":[692,704,716,728],"an":[694,706,718,730],"entity's":[695,707,719,731],"Board":[696,708,720,732],"Directors":[698,710,722,734],"advisory":[700,712,724,736],"committees;":[701,713,725],"Innate:":[702],"BMS:":[714],"AstraZeneca:":[726,871],"committees.":[737],"Desai:":[738],"Kura":[739],"Oncology:":[740],"Consultancy;":[741,745,747,749,828,831,833,835,839,842,844,846,848,850,852,855,858,860,862,864,866,868,870,872,874,879],"Bristol":[742,773,836],"Myers":[743,774,837],"Squibb:":[744,775,838],"Agios:":[746,863],"Takeda:":[748,800],"Janssen":[750],"R&D:":[751],"Research":[752,755,777,796,805,809,816,820,876],"Funding;":[753,778,806,810,817,877],"Astex:":[754,867],"Funding.":[756,821],"Ritchie:":[757],"Protaganist:":[758],"Honoraria;":[760,802,813],"Incyte:":[761],"Honoraria,":[763,792],"Speakers":[764,771,788,798],"Bureau;":[765,772,789,799],"Celgene/BMS:":[766],"Other:":[768,793],"travel":[769,794],"support,":[770,795],"ARIAD":[779],"Pharmaceuticals:":[780],"Ended":[781],"employment":[782],"past":[785],"24":[786],"Novartis:":[790,843],"Funding,":[797],"Astellas:":[803,869],"NS":[807],"Pharma:":[808],"Abbvie:":[811],"Jazz:":[814,834],"Pfizer:":[818,878],"Roboz:":[822],"MEI":[823],"Pharma":[824],"IDMC":[826],"Chair:":[827],"Daiichi":[829],"Sankyo:":[830],"Helsinn:":[832],"Glaxo":[840],"SmithKline:":[841],"Janssen:":[845,875],"Otsuka:":[847],"Celgene:":[849],"Mesoblast:":[851],"Blueprint":[853],"Medicines:":[854],"Jasper":[856],"AbbVie:":[859],"Actinium:":[861],"Amgen:":[865],"Bayer:":[873],"Roche/Genentech:":[880],"Consultancy.":[881]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-12-06T00:00:00"}